少突胶质细胞谱系细胞与抑郁症
抑郁症影响全球超3亿人,现有对症治疗但发病机制未达成共识。本综述总结少突胶质细胞谱系细胞(含祖细胞和成熟少突胶质细胞)参与抑郁症发病的最新发现,并讨论靶向这些细胞作为新型治疗策略的方法。
要点
- 少突胶质细胞谱系细胞具有形成髓鞘、代谢支持轴突和介导神经可塑性等功能。
- 这些特化胶质细胞已被牵涉到抑郁症等精神疾病中。
- 靶向少突胶质细胞谱系细胞可能成为治疗抑郁症的新策略。
核心结论
- 少突胶质细胞谱系细胞可能参与抑郁症的发病机制,靶向这些细胞是治疗抑郁症的新策略。
研究设计与样本
- 本文为综述,总结近期关于少突胶质细胞谱系细胞参与抑郁症发病机制的研究发现。
主要发现
- 少突胶质细胞谱系细胞包括少突胶质祖细胞和成熟少突胶质细胞,具有形成髓鞘、代谢支持轴突和介导神经可塑性等功能。
- 这些特化胶质细胞已被牵涉到抑郁症等精神疾病中。
临床怎么用
- 靶向少突胶质细胞谱系细胞可能作为治疗抑郁症的新型策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Depression is a common mental illness, affecting more than 300 million people worldwide. Decades of investigation have yielded symptomatic therapies for this disabling condition but have not led to a consensus about its pathogenesis. There are data to support several different theories of causation, including the monoamine hypothesis, hypothalamic-pituitary-adrenal axis changes, inflammation and immune system alterations, abnormalities of neurogenesis and a conducive environmental milieu. Research in these areas and others has greatly advanced the current understanding of depression; however, there are other, less widely known theories of pathogenesis. Oligodendrocyte lineage cells, including oligodendrocyte progenitor cells and mature oligodendrocytes, have numerous important functions, which include forming myelin sheaths that enwrap central nervous system axons, supporting axons metabolically, and mediating certain forms of neuroplasticity. These specialized glial cells have been implicated in psychiatric disorders such as depression. In this review, we summarize recent findings that shed light on how oligodendrocyte lineage cells might participate in the pathogenesis of depression, and we discuss new approaches for targeting these cells as a novel strategy to treat depression.
引用
- Zhou B, Zhu Z, Ransom BR, et al. Oligodendrocyte lineage cells and depression. Mol Psychiatry. 2020. PMID: 33144710. doi:10.1038/s41380-020-00930-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。